|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.5 USD | +1.20% |
|
+2.16% | +8.88% |
| 09:19pm | Morgan Stanley's Gorman says banking industry consolidation is "inevitable" | RE |
| 07:04pm | JPMorgan Chase Stock Rebound Seen After a Tumble Amid Buyback Concerns, Morgan Stanley Says | MT |
FRANKFURT (Reuters) - The family behind German generic drugmaker Dermapharm is preparing to take the company public with the help of Morgan Stanley, trade publication Apotheke Adhoc cited people familiar with the matter as saying.
Sources told Reuters in April 2016 that owner Wilhelm Beier had short-listed two financial investors as prospective buyers with one bid reaching about 1.1 billion euros (£0.98 billion) but a deal was never clinched.
Dermapharm and Morgan Stanley declined to comment.
(Reporting by Ludwig Burger and Arno SchuetzeEditing by Maria Sheahan)
| 1st Jan change | Capi. | |
|---|---|---|
| +8.88% | 163B | |
| +21.94% | 157B | |
| +14.68% | 144B | |
| +25.86% | 120B | |
| -5.55% | 37.16B | |
| +11.92% | 25.94B | |
| -3.91% | 21.35B | |
| +18.46% | 20.13B | |
| +41.68% | 17.34B | |
| +0.65% | 16.28B |
MORGAN STANLEY 
